ADELLA MUJKANOVIC: Open Payments
NPI 1083081830 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$669 in 16 payments from 8 companies in 2025. Trend: 2023 $8,648 · 2024 $486 · 2025 $669
Food & beverage: $669
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $418 |
| Novo Nordisk Inc | 3 | $79 |
| SOBI, INC | 2 | $52 |
| SERVIER PHARMACEUTICALS LLC | 2 | $41 |
| Novartis Pharmaceuticals Corporation | 1 | $30 |
| PharmaEssentia USA Corporation | 1 | $18 |
| Incyte Corporation | 1 | $17 |
| HEMA Biologics, LLC | 1 | $15 |
Products named: WAYRILZ, CABLIVI, Vonjo, Tibsovo, AYVAKIT, Fabhalta, ALTUVIIIO, Alhemo.
Industry payments across MO — which companies pay providers there.
